These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9067994)

  • 1. [Pharmacological characteristics of the long-acting beta-blocker "bopindolol"].
    Nagatomo T; Hosohata Y; Ohnuki T; Suzuki J
    Nihon Yakurigaku Zasshi; 1997 Jan; 109(1):1-12. PubMed ID: 9067994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypotensive effect of bopindolol in pithed rats.
    Tanaka H; Takahashi S; Shigenobu K
    Gen Pharmacol; 1993 Mar; 24(2):373-5. PubMed ID: 8097742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chronic administration of bopindolol on the binding characteristics of cardiac alpha 1H-, alpha 1L-, beta 1- and beta 2-adrenoceptor subtypes in cardiac muscles of spontaneously hypertensive rats (SHR).
    Hosohata Y; Sasaki K; Maruyama K; Ohnuki T; Hattori K; Suzuki J; Watanabe K; Nagatomo T
    Biol Pharm Bull; 1996 Jul; 19(7):932-5. PubMed ID: 8839963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bopindolol: a slowly dissociating antagonist from the beta-adrenoceptors in guinea pig atria.
    Hosohata Y; Hattori K; Shen Y; Okuyama M; Kaneko H; Ohnuki T; Suzuki J; Nagatomo T
    Pharmacology; 1998 Oct; 57(4):180-7. PubMed ID: 9730775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of chronic oral administration of a new beta-blocker, bopindolol, on serum lipoprotein concentrations and blood pressure of spontaneously hypertensive rats.
    Ishihara T; Chin WP; Yoshida Y; Sun HT; Mitomi A; Ishibashi T; Tamura K; Imai S
    Arch Int Pharmacodyn Ther; 1989; 302():145-57. PubMed ID: 2576891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiohemodynamic effects of bopindolol in normotensive conscious dogs. A comparative study with pindolol.
    Ishibashi T; Mitomi A; Tatebe S; Imai S
    Arzneimittelforschung; 1989 Apr; 39(4):454-7. PubMed ID: 2568836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Beta-blocking actions and the partial agonist activity of bopindolol, a new beta-adrenoceptor antagonist, and its two metabolites].
    Chin WP; Sun HT; Kawada T; Imai S
    Nihon Yakurigaku Zasshi; 1989 Jul; 94(1):27-33. PubMed ID: 2571551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-blocking action of bopindolol, a new beta-blocker, and its active metabolites in open chest dogs.
    Okuhira M; Nakazawa M; Kameda H; Hara K; Kawada T; Imai S
    Arch Int Pharmacodyn Ther; 1993; 323():5-15. PubMed ID: 7902696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Certain beta-blockers can decrease beta-adrenergic receptor number: I. Acute reduction in receptor number by tertatolol and bopindolol.
    De Blasi A; Fratelli M; Marasco O
    Circ Res; 1988 Aug; 63(2):273-8. PubMed ID: 2899461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bopindolol is a slowly dissociating beta 1-adrenoceptor antagonist when compared to other beta-blockers.
    Hosohata Y; Sasaki K; Shen Y; Hattori K; Suzuki J; Nagatomo T
    Biol Pharm Bull; 1995 Aug; 18(8):1066-71. PubMed ID: 8535397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bopindolol: pharmacological basis and clinical implications.
    Nagatomo T; Hosohata Y; Ohnuki T; Nakamura T; Hattori K; Suzuki J; Ishiguro M
    Cardiovasc Drug Rev; 2001; 19(1):9-24. PubMed ID: 11314603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological experiments in healthy volunteers with bopindolol, a long-acting beta-adrenoceptor blocking drug with partial agonist activity.
    Aellig WH
    Br J Clin Pharmacol; 1985 Jun; 19(6):775-81. PubMed ID: 2862891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bopindolol. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.
    Harron DW; Goa KL; Langtry HD
    Drugs; 1991 Jan; 41(1):130-49. PubMed ID: 1706984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustaining effects of bopindolol on inhibitory chronotropic actions in guinea pig atria.
    Hattori K; Suzuki J; Hosohata Y; Ohnuki T; Nakamura T; Watanabe K; Muramatsu I; Nagatomo T
    Pharmacology; 1999 Oct; 59(4):183-91. PubMed ID: 10474078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The offset of beta-adrenoceptor antagonism of the responses of the rat right ventricle to isoprenaline.
    Doggrell SA; Henderson CJ
    J Auton Pharmacol; 1998 Oct; 18(5):263-9. PubMed ID: 9831226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of renin inhibition by beta adrenergic blocking agents. Effects of dl-, d-, l-propranolol and pindolol on renin release.
    Saruta T; Eguchi T; Nakamura R; Misumi J; Kondo K; Oka M
    Jpn Heart J; 1980 Jan; 21(1):103-9. PubMed ID: 6102616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacological studies with the long-acting beta-adrenoceptor blocking drug bopindolol.
    Aellig WH
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S12-5. PubMed ID: 2439811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antioxidative action of the beta-adrenoceptor antagonist bopindolol and its metabolite 18-502.
    Aniya Y; Fong KF; Naito A; Sakanashi M
    Jpn J Pharmacol; 1995 Jul; 68(3):323-9. PubMed ID: 7474556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical responses of rat ileum to pindolol, cyanopindolol and iodocyanopindolol.
    Hoey A; Jackson C; Pegg G; Sillence M
    Br J Pharmacol; 1996 Feb; 117(4):712-6. PubMed ID: 8646418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrinsic sympathomimetic activity of (-)-pindolol mediated through a (-)-propranolol-resistant site of the beta1-adrenoceptor in human atrium and recombinant receptors.
    Joseph SS; Lynham JA; Molenaar P; Grace AA; Colledge WH; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):496-503. PubMed ID: 14608456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.